Using a nerve block technique to manage pain after gallbladder surgery
Effectiveness Of Modified-Thoracoabdominal Nerve Block Perichondrial Approach (M-TAPA) Post-Operative Analgesia Compared To Intravenous Opioids In Laparoscopic Cholecystectomy Patients
This study is testing a new nerve block technique to see if it can help people manage pain better after gallbladder surgery compared to just using opioids.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 42 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | Udayana University Academic / other |
| Locations | 1 site (Denpasar, Bali) |
| Trial ID | NCT06652581 on ClinicalTrials.gov |
What this trial studies
This clinical trial aims to evaluate the effectiveness of the Modified Thoracoabdominal Perichondrial Approach (M-TAPA) for pain management in patients undergoing laparoscopic cholecystectomy. Participants will be divided into two groups: one receiving the M-TAPA nerve block for postoperative analgesia and the other receiving only intravenous opioids. The study will assess pain relief duration, pain intensity, and total opioid consumption post-surgery. Monitoring for side effects will be conducted to ensure patient safety throughout the trial.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18-65 with a body mass index between 17.5 and 30, classified as ASA I-II.
Not a fit: Patients who refuse participation, have local infections, or are chronic analgesic users may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and recovery for patients undergoing gallbladder surgery.
How similar studies have performed: Other studies have shown promising results with similar nerve block techniques, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patient 18-65 yeasr old 2. IMT 17.5-30 kg/m2 3. Patient with ASA I-II Exclusion Criteria: 1. Patient Refusal 2. Local Infection 3. Chronic Analgesia drug user
Where this trial is running
Denpasar, Bali
- Prof I.G.N.G Ngoerah General Hospital — Denpasar, Bali, Indonesia (Recruiting)
Study contacts
- Principal investigator: Who Who — World Health Organization
- Study coordinator: Amelia Christiana, MD
- Email: ameliachristiana@student.unud.ac.id
- Phone: +6282398565260
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.